Prophylactic treatment of ganciclovir to prevent and cure cytomegalovirus infection after renal transplantation: A systematic review

Fudan University Journal of Medical Sciences

Volumn 37, Issue 2, 2010, Pages 131-139

  Zhang, Li Feng ^a   Tian, Jin Hui ^a   Yi, Kang ^a   Jia, Wen Qin ^a   Yang, Ke Hu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Cytomegalovirus; Ganciclovir; Prophylactic; Renal transplantation; Systematic review

Indexed keywords

EID: 77951550446     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival[J]. Kidney Int, 2004, 66(1 ): 329-337. (Pubitemid 38870110)
2. Murray BM, Subramaniam S. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients [J]. Transpl Infect Dis, 2004 ,6: 3-9. (Pubitemid 38954921)
3. Sagedal S, Nordal XP, Hartmann A. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study [J]. Nephrol Dial Transplant, 2003, 18, 1899-1908. (Pubitemid 37098564)
4. Pascual J, Alarcon MC, Mareen R, et al. Cytomegalovirus infection after renal transplantation: selective prophylaxis and treatment[J]. Transplant Proc, 2003, 35: 1756-1757. (Pubitemid 37093699)
5. Reischig T, Opatrny Jr. K, Treska V, et al. Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients [J]. Kidney Blood Pressure Res, 2005, 4: 218-225. (Pubitemid 43048611)
6. Rondeau E, Bourgeon B, Peraldi MN, et al. Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients[J]. Nephrol Dial Transplantation, 1993, 8, 858-862. (Pubitemid 23286997)
7. Ahsan N, Holman MJ, Yang HC. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients[J]. Clin Transplantation, 1997, 25: 633-639. (Pubitemid 27526816)
8. Reischig T, Opatrny Jr. K, Bouda M, et al. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation[J]. Transplant Int, 2002, 15, 615-622. (Pubitemid 36068176)
9. Reischig T, Jindra P, Mares J, et al. Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection[J]. Transplantation, 2005, 79(3): 317-324. (Pubitemid 40299538)
10. Pavlopoulou ID, Syriopoulou VP, Chelioti H, et al. A comparative randomised study of valacyclovir vs oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients[J]. Clin Microbiol Infect, 2005, 11: 736-743. (Pubitemid 41167340)
11. Brennan DC.Garlock KA, Singer GG, et al. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients [J]. Transplantation, 1997, 64(12), 1843-1846.
12. Flechner SM, Avery RK, Fisher R, et al. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients [J]. Transplantation, 1998, 66 (12): 1682-1688. (Pubitemid 29034991)
13. Conti DJ, Freed BM, Gruber SA, et al. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin[J]. Arch Surg, 1994, 129: 443-447.
14. Morales E, Andres A, Gonzalez E, et al. Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy [J]. Transplantation Proc, 2002, 34, 73-74. (Pubitemid 34311575)
15. Said T, Nampoory MR, Pacsa AS, et al. Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis, in kidney transplant recipients[J]. Transplantation Proc, 2007, 39, 997-999. (Pubitemid 46764885)
16. Reddy SP, Handa A, Tan L, et al. Low-dose valacielovir prophylaxis against cytomegalovirus disease in renal transplant recipients[J]. Transpl Int, 2003, 16(10): 726-729. (Pubitemid 37408593)